Bladder Cancer, a common urological malignancy, is marked by uncontrolled cell growth in the bladder lining. Treatment options depend on the cancer’s stage, muscle involvement, and patient health. Two primary surgical interventions are Transurethral Resection of Bladder Tumor (TURBT) and Cystectomy, each tailored to specific cases.
Endoscopic Surgery: TURBT
TURBT is a minimally invasive procedure aimed at diagnosing and treating Non-Muscle Invasive Bladder Cancer (NMIBC).
Indications
- Non-Muscle Invasive Cancer: Tumors limited to the bladder lining.
- Diagnosis: Also used to collect tissue samples for pathology.
Procedure Overview
- Anesthesia: Performed under local or general anesthesia.
- Visualization: A cystoscope with a camera and surgical tools is inserted through the urethra.
- Tumor Removal: The tumor is excised using a resectoscope, and the tissue is sent for analysis.
- Post-Procedure: A catheter may temporarily drain urine for bladder healing.
Recovery and Postoperative Care
- Hospital Stay: Most patients go home the same day.
- Pain Management: Mild discomfort is manageable with medication.
- Follow-Up: Regular cystoscopies monitor for recurrence.
Advantages
- Minimally invasive with faster recovery.
- Preserves bladder function for normal urinary control.
- Quick return to daily activities.
Risks
- Bleeding: Usually mild, but severe cases may require intervention.
- Infection: Risk of urinary tract infections.
- Perforation: Rarely, the bladder wall may be punctured.
Open Surgery: Cystectomy
Cystectomy involves the partial or total removal of the bladder, commonly used for muscle-invasive bladder cancer (MIBC) or recurring non-responsive tumors.
Indications
- Muscle-Invasive Cancer: Cancer spreading into the bladder muscle.
- Recurrent Tumors: Persistent tumors unresponsive to TURBT or other treatments.
Procedure Overview
- Anesthesia: Conducted under general anesthesia.
- Incision: A large abdominal incision provides access.
- Bladder Removal: Entire or partial bladder removal, often including lymph nodes.
- Urinary Diversion: A new route for urine is created, such as a neobladder or urostomy.
Recovery and Postoperative Care
- Hospital Stay: Typically several days.
- Pain Management: Managed with prescribed medications.
- Activity Restrictions: Avoid strenuous activities for weeks.
- Follow-Up: Ensures proper healing and detects complications.
Advantages
- Comprehensive tumor removal for muscle-invasive cancer.
- Facilitates thorough pathological evaluation.
Risks
- Infection: At the surgical site or in urinary pathways.
- Bleeding: Potentially requiring transfusion.
- Urinary Issues: Complications with urinary diversion, such as leaks or blockages.
Long-Term Outlook
- TURBT offers favorable outcomes for NMIBC, especially with vigilant follow-up.
- Cystectomy is effective for MIBC but often necessitates adjunct therapies, like chemotherapy or immunotherapy, and long-term monitoring.
Choosing the Right Approach
The choice between TURBT and cystectomy hinges on cancer stage, muscle invasion, and patient health.
Call us today to consult a urologist, to evaluate your options, and to create a personalized treatment plan for best outcome.